Justin A. Renz
Overview
Justin A. Renz received an average of $4M in total compensation, including $281K in salary, at Karyopharm Therapeutics from 2014 to 2016.
Source: SEC filings on April 28, 2017 and April 29, 2016.
Related executives
We found ten more executives who work or worked at Karyopharm Therapeutics.
Richard Paulson
Karyopharm Therapeutics
Chief Executive Officer
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
Michael Mason
Karyopharm Therapeutics
Chief Financial Officer
Jatin Shah
Karyopharm Therapeutics
Chief Medical Officer
Ran Frenkel
Karyopharm Therapeutics
Executive Vice President, Chief Development Officer
Christopher Primiano
Karyopharm Therapeutics
General Counsel
Anand Varadan
Karyopharm Therapeutics